Literature DB >> 8151351

Hemodynamics of subarachnoid hemorrhage arrest.

P W McCormick1, J McCormick, J M Zabramski, R F Spetzler.   

Abstract

Subarachnoid hemorrhage (SAH) causes a spectrum of clinical syndromes from mild discomfort to rapid brain death. The reason for these heterogeneous consequences is poorly understood. A canine autologous shunt model of SAH was used to study this problem. The duration and volume of hemorrhage into the suprasellar cistern at each animal's mean arterial blood pressure were measured at variable hemorrhage flow rates. At high rates of bleeding in seven dogs (18.7 +/- 2.2 ml/min, mean +/- standard deviation), hemorrhage duration was significantly less (191 +/- 116 seconds, p < 0.03) and hemorrhage volume was significantly greater (15.1 +/- 7.0 ml, p < 0.05) than at low flow rates. At low flow rates of bleeding in nine dogs (4.4 +/- 2.2 ml/min), hemorrhage duration was 394 +/- 202 seconds and volume was 10.9 +/- 6.5 ml. Cerebral perfusion pressure (CPP) decreased at all hemorrhage rates but never to 0 mm Hg (perfusion arrest). No correlation between a decrease in CPP and SAH volume or duration was identified. The initial flow rate of SAH had a positive linear correlation with the volume of hemorrhage (23 dogs, r = 0.64, p < 0.01). The data suggest that initial SAH flow rate, and not CPP, has a primary influence on hemorrhage arrest. This finding may influence the clinical rationale for acute management of SAH-induced brain injury.

Entities:  

Mesh:

Year:  1994        PMID: 8151351     DOI: 10.3171/jns.1994.80.4.0710

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Continuous bleeding from a basilar terminus aneurysm imaged with CT angiography and conventional angiography.

Authors:  S Andrew Josephson; William P Dillon; Christopher F Dowd; Reza Malek; Michael T Lawton; Wade S Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage.

Authors:  Giovanni Grasso; Michele Buemi; Concetta Alafaci; Alessandra Sfacteria; Marcello Passalacqua; Alessio Sturiale; Gioacchino Calapai; Gionata De Vico; Giuseppe Piedimonte; Francesco M Salpietro; Francesco Tomasello
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

3.  Hyperacute Vasospasm After Aneurysmal Subarachnoid Hemorrhage.

Authors:  B Bar; L MacKenzie; R W Hurst; R Grant; J Weigele; P K Bhalla; M A Kumar; M F Stiefel; J M Levine
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

4.  The rabbit shunt model of subarachnoid haemorrhage.

Authors:  Serge Marbacher; Edin Nevzati; Davide Croci; Salome Erhardt; Carl Muroi; Stephan M Jakob; Javier Fandino
Journal:  Transl Stroke Res       Date:  2014-10-19       Impact factor: 6.829

5.  Brain energy metabolism in the acute stage of experimental subarachnoid haemorrhage: local changes in cerebral glucose utilization.

Authors:  D d'Avella; R Cicciarello; M Zuccarello; F Albiero; A Romano; F F Angileri; F M Salpietro; F Tomasello
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Feasible Ingredient for a Successful Medical Recipe.

Authors:  Giovanni Grasso; Giovanni Tomasello; Marcello Noto; Concetta Alafaci; Francesco Cappello
Journal:  Mol Med       Date:  2015-11-16       Impact factor: 6.354

7.  Predictive model for patients with poor-grade subarachnoid haemorrhage in 30-day observation: a 9-year cohort study.

Authors:  Sebastian Szklener; Anna Melges; Agnieszka Korchut; Wojciech Zaluska; Tomasz Trojanowski; Robert Rejdak; Konrad Rejdak
Journal:  BMJ Open       Date:  2015-06-12       Impact factor: 2.692

Review 8.  Imaging of small animal peripheral artery disease models: recent advancements and translational potential.

Authors:  Jenny B Lin; Evan H Phillips; Ti'Air E Riggins; Gurneet S Sangha; Sreyashi Chakraborty; Janice Y Lee; Roy J Lycke; Clarissa L Hernandez; Arvin H Soepriatna; Bradford R H Thorne; Alexa A Yrineo; Craig J Goergen
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.